Thrombolytic therapy for acute ischemic stroke.
Perl
J
J
Department of Endovascular Neurosurgery and Neuroradiology, Cleveland Clinic Foundation S80, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Samples
S D
SD
D000818:Animals; D001157:Arterial Occlusive Diseases / Q000150:complications / Q000188:drug therapy; D002545:Brain Ischemia / Q000188:drug therapy* / Q000209:etiology*; D005060:Europe / Q000453:epidemiology; D005343:Fibrinolytic Agents / Q000592:standards / Q000627:therapeutic use; D005544:Forecasting; D006493:Heparin / Q000600:supply & distribution / Q000627:therapeutic use; D006801:Humans; D007261:Infusions, Intra-Arterial; D007262:Infusions, Intravenous; D020768:Middle Cerebral Artery / Q000473:pathology; D017410:Practice Guidelines as Topic; D020521:Stroke / Q000188:drug therapy* / Q000209:etiology*; D015912:Thrombolytic Therapy / Q000592:standards; D010959:Tissue Plasminogen Activator / Q000592:standards / Q000627:therapeutic use; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D014486:United States Food and Drug Administration
D005343:Fibrinolytic Agents; D006493:Heparin; D010959:Tissue Plasminogen Activator